Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy

Table 6

Multivariate survival analysis of OS for LACSCC patients with neutropenia.

Clinicopathologic characteristics		SE	Wald	value	HR	95% CI
Lymph node metastasis	0.668	0.696	0.921	0.337	1.951	0.498–7.635
FIGO stage	0.326	0.753	0.188	0.665	1.385	0.317–6.056
RNG	1.833	0.956	3.678	0.055	6.252	0.961–40.687

OS, overall survival; LACSCC, locally advanced cervical squamous cell carcinomas; FIGO, International Federation of Gynecology and Obstetrics; RNG, responses of neutrophil to granulocyte colony-stimulating factors.